Global Self-Monitoring Blood Glucose (SMBG) Devices Market Size, Share, Opportunities, And Trends By Type (Blood Glucose Meters, Testing Strips, Lancets & Lancing Devices), By Indication (Type I Diabetes, Type II Diabetes, Gestational Diabetes), By End Users (Hospitals And Clinics, Ambulatory Care Settings, Diagnostic Centres, Home Care Settings), And By Geography - Forecasts From 2024 To 2029

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base and Forecast Years Timeline

1.8. Key Benefits for the Stakeholder

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Analyst View

5. GLOBAL SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES MARKET BY TYPE

5.1. Introduction

5.2. Blood Glucose Meter

5.3. Testing Strips

5.4. Lancets & Lancing Devices

6. GLOBAL SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES MARKET BY INDICATION

6.1. Introduction

6.2. Type 1 Diabetes

6.3. Type 2 Diabetes

6.4. Gestational Diabetes

7. GLOBAL SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES MARKET BY END-USER

7.1. Introduction

7.2. Hospitals and Clinics

7.3. Ambulatory Care Settings

7.4. Diagnostics Centers

7.5. Home Care Settings

8. GLOBAL SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. Germany

8.4.2. France

8.4.3. United Kingdom 

8.4.4. Spain

8.4.5. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Israel

8.5.4. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. India

8.6.3. South Korea

8.6.4. Taiwan

8.6.5. Thailand

8.6.6. Indonesia

8.6.7. Japan

8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Abbott

10.2. Hoffmann-La Roche Ltd.

10.3. Lifescan Inc.

10.4. Bayer Corporation

10.5. ARKRAY, Inc.

10.6. B. Braun Melsungen AG

10.7. Sanofi

10.8. Ypsomed AG

10.9. Bionime Corporation

10.10. Ascensia Diabetes Care Holdings AG